Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Maintains Buy on RxSight, Raises Price Target to $22

Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and raises the price target from $19 to $22.
byBenzinga Newsdesk
August 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and raises the price target from $19 to $22.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0